Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort-Reference-Cited by-同舟云学术

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort

Published:2011-04-20 Issue:8b Volume:108 Page:E237-E244
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Trottier Greg,Roobol Monique J.,Lawrentschuk Nathan,Boström Peter J.,Fernandes Kimberly A.,Finelli Antonio,Chadwick Karen,Evans Andrew,van der Kwast Theodorus H.,Toi Ants,Zlotta Alexandre R.,Fleshner Neil E.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10207.x/fullpdf

Reference26 articles.

1. Mortality results from a randomized prostate-cancer screening trial;Andriole;N Engl J Med,2009

2. Screening and prostate-cancer mortality in a randomized European study;Schroder;N Engl J Med,2009

3. Introducing the 2010 American Cancer Society prostate cancer screening guideline;Brawley;CA Cancer J Clin,2010

4. Prostate specific antigen best practice statement: 2009 update;Greene;J Urol,2009

5. European Association of Urology position statement on screening for prostate cancer;Abrahamsson;Eur Urol,2009

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk calculators for the detection of prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-06-03

2. BioPrev-C – development and validation of a contemporary prostate cancer risk calculator;Frontiers in Oncology;2024-02-21

3. Comparison between the European Randomized Study for Screening of Prostate Cancer (ERSPC) and Prostate Biopsy Collaborative Group (PBCG) risk calculators: Prediction of clinically significant Prostate Cancer risk in a cohort of patients from Argentina;Actas Urológicas Españolas (English Edition);2023-10

4. Comparación entre las calculadoras de riesgo del European Randomized Study for Screening of Prostate Cancer (ERSPC) y Prostate Biopsy Collaborative Group (PBCG): predicción del riesgo de cáncer de próstata clínicamente significativo en una cohorte de pacientes de Argentina;Actas Urológicas Españolas;2023-08

5. Augmenting prostate magnetic resonance imaging reporting to incorporate diagnostic recommendations based upon clinical risk calculators;World Journal of Radiology;2022-08-28